AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Eon rockets past $1 billion valuation in under a year, raising tens of millions more
2
Monday.com founders: “We have everything needed to get to $10 billion in revenue”
3
Israel’s next tech boom: Pioneering the future of global defensetech
4
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news

Reorganization

16 stories about Reorganization
אלון בר שני מנכל חברת אינדיגו

Alon Bar-Shany to leave HP Indigo after 25 years

09.06.20|Golan Hazani
HP has long been attempting to carry out a restructuring but Bar-Shany has vehemently opposed it, said a person familiar with the move
אתר טבע כפר סבא

Teva to Close Missouri Plant, Report Says

29.08.19|Tzally Greenberg
Teva’s manufacturing plant in Israeli city Netanya is also slated for final closure in early 2020, as part of the company’s reorganization plan
default image

PayPal Cutting Workforce in Israel As Part of Global Reorganization

04.03.19|Meir Orbach
The company has summoned 30 of its 250 Israeli employees for a pre-termination hearing on Monday
הפגנה מפגינים פיטורים טבע אשדוד

Teva Signs Deal to Sell Closed Israeli Factory

03.02.19|Lilach Baumer
In December 2017, Teva announced plans to sell or close many of its manufacturing facilities and let 25% of global employees go as part of a debt management plan
הפגנה מפגינים פיטורים טבע אשדוד

Teva Outsources Manufacturing in Anticipation of Israeli Plant Closure

27.08.18|Golan Hazani
The debt-laden drugmaker announced an aggressive reorganization plan in December, consisting of wide-spread asset divestments and layoffs, including in its home country of Israel
קאר שולץ מנכל טבע

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich
Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price
מטה טבע פתח תקווה

Building on Strong First Quarter, Teva Raises 2018 Outlook

03.05.18|Lilach Baumer and Dror Reich
The company reported a 10% decrease in revenues compared to 2017, largely due to North American Copaxone troubles, but beat analyst expectations
מנכ"ל טבע החדש קור שולץ 2

Teva Shut Down New York, Washington Offices, Says CEO

23.02.18|Dror Reich
In a meeting with investors in Israel, CEO Kåre Schultz said the Washington offices were used mainly by lobbyists, for which Teva has no further need
מוסף 16.5 הון אנושי סול ג'יי בארר Sol J. Barer

After Announcing Restructuring Plan, Teva's Board of Directors Takes Paycut

11.01.18|Lilach Baumer
In December, the generic drugmaker announced a plan to let go 14,000 employees
מנכ"ל טבע החדש קור שולץ 2

As Part of Cost-Cutting Plan, Teva Will Shut Down Twenty or More Manufacturing Sites

10.01.18|Lilach Baumer
The drugmaker will shut down 20-25 manufacturing sites in the next two years, CEO Kåre Schultz said Monday
ליעם גלין נשיא מנכ"ל מטומי

Digital Marketing Company Matomy Media Replaces CEO after Ten Months

09.01.18|Lilach Baumer
Current CEO Sagi Niri has carried out a reorganization plan in 2017, selling non-core assets and streamlining the company's operations
עובדי טבע חוסמים את אזור הכניסה ל ירושלים

Teva CEO to Netanyahu: Layoffs will Proceed as Planned

19.12.17|Omri Milman
In a statement, the company said it rejects the Israeli government’s appeal to withdraw cutback plans
default image

Following Restructuring Announcements, Teva Reinstated as Israel’s Biggest Company

18.12.17|Lilach Baumer
Teva's stock jumped 18.7% on the New York Stock Exchange between Thursday market opening and Friday market close. Israeli Prime Minister Benjamin Netanyahu is expected to meet with CEO Kåre Schultz Tuesday
אחרי ה שביתה נתב"ג טבע פיטורים טיסות טרמינל

Tel Aviv Airport, Stock Market Open as Solidarity Strike Ends

17.12.17|Lior Gutman, Omri Milman and Micky Grunfeld
Israel’s largest labor union called for a half-day strike on Thursday, in support of Teva employees
יצחק פטרבורג

Former Chairman Yitzhak Peterburg Leaves Teva

13.12.17|Lilach Baumer
Mr. Peterburg was the troubled drugmaker's interim CEO between February and November 1, when Kåre Schultz took helm
מנכ"ל טבע החדש קור שולץ

New CEO Steers Teva Back to Generics

28.11.17|Golan Hazani and Dror Reich
A reorganization plan announced by the company Monday would see the troubled drugmaker return to its core competencies, despite market pressures